| Abbreviated name . | Genotype . | Phenotype . | Vivarium . | Strain . |
|---|---|---|---|---|
| Krit1ECKO, Krit1BECKO | VE-Cadherin-CreERT2; Krit1fl/fl or Slco1c1(BAC)-Cre; Krit1fl/fl | Numerous lesions in the hindbrain | University of Pennsylvania | Mixed |
| Ccm2ECKO | VE-Cadherin-CreERT2; Ccm2fl/fl | Same as Krit1(B)ECKO | Centenary Institute | Mixed |
| N/A | PDGFb-CreERT2; Pdcd10fl/− | Same as Krit1(B)ECKO | Duke University | C57BL/6J |
| Krit1ECKO; Adamts4−/− | VE-Cadherin-CreERT2; Krit1fl/fl; Adamts4−/− | No reduction in lesion formation | University of Pennsylvania | Mixed |
| Krit1ECKO; Adamts1fl/− | VE-Cadherin-CreERT2; Krit1fl/fl; Adamts1fl/− | No reduction in lesion formation | University of Pennsylvania | Mixed |
| Krit1ECKO; Adamts1fl/fl; Adamts4−/− | VE-Cadherin-CreERT2; Krit1fl/fl; Adamts1fl/fl; Adamts4−/− | No reduction in lesion formation | University of Pennsylvania | Mixed |
| Ccm2ECKO; Adamts5−/− | VE-Cadherin-CreERT2; Ccm2fl/fl; Adamts5−/− | Significant reduction in lesion formation | Centenary Institute | Mixed |
| Krit1ECKO; Adamts5fl/fl; | VE-Cadherin-CreERT2; Krit1fl/fl; Adamts5fl/fl; | Significant reduction in lesion formation | University of Pennsylvania | Mixed |
| ADAMTS5BEC-GOF + doxycycline | Slco1c1(BAC)-Cre; LSL-rtTA; tetO-Adamts5 | Nascent CCM-like vascular changes | University of Pennsylvania | Mixed |
| Krit1BECKO + doxycycline | Slco1c1(BAC)-Cre; Krit1fl/fl | Significant reduction in lesion formation | University of Pennsylvania | Mixed |
| Krit1BECKO; ADAMTS5BEC-GOF + doxycycline | Slco1c1(BAC)-Cre; Krit1fl/fl; LSL-rtTA; tetO-Adamts5 | Increase in lesion formation | University of Pennsylvania | Mixed |
| Krit1ECKO; VcanRC/+ | VE-Cadherin-CreERT2; Krit1fl/fl; VcanRC/+ | Significant reduction in lesion formation | University of Pennsylvania | Mixed |
| Abbreviated name . | Genotype . | Phenotype . | Vivarium . | Strain . |
|---|---|---|---|---|
| Krit1ECKO, Krit1BECKO | VE-Cadherin-CreERT2; Krit1fl/fl or Slco1c1(BAC)-Cre; Krit1fl/fl | Numerous lesions in the hindbrain | University of Pennsylvania | Mixed |
| Ccm2ECKO | VE-Cadherin-CreERT2; Ccm2fl/fl | Same as Krit1(B)ECKO | Centenary Institute | Mixed |
| N/A | PDGFb-CreERT2; Pdcd10fl/− | Same as Krit1(B)ECKO | Duke University | C57BL/6J |
| Krit1ECKO; Adamts4−/− | VE-Cadherin-CreERT2; Krit1fl/fl; Adamts4−/− | No reduction in lesion formation | University of Pennsylvania | Mixed |
| Krit1ECKO; Adamts1fl/− | VE-Cadherin-CreERT2; Krit1fl/fl; Adamts1fl/− | No reduction in lesion formation | University of Pennsylvania | Mixed |
| Krit1ECKO; Adamts1fl/fl; Adamts4−/− | VE-Cadherin-CreERT2; Krit1fl/fl; Adamts1fl/fl; Adamts4−/− | No reduction in lesion formation | University of Pennsylvania | Mixed |
| Ccm2ECKO; Adamts5−/− | VE-Cadherin-CreERT2; Ccm2fl/fl; Adamts5−/− | Significant reduction in lesion formation | Centenary Institute | Mixed |
| Krit1ECKO; Adamts5fl/fl; | VE-Cadherin-CreERT2; Krit1fl/fl; Adamts5fl/fl; | Significant reduction in lesion formation | University of Pennsylvania | Mixed |
| ADAMTS5BEC-GOF + doxycycline | Slco1c1(BAC)-Cre; LSL-rtTA; tetO-Adamts5 | Nascent CCM-like vascular changes | University of Pennsylvania | Mixed |
| Krit1BECKO + doxycycline | Slco1c1(BAC)-Cre; Krit1fl/fl | Significant reduction in lesion formation | University of Pennsylvania | Mixed |
| Krit1BECKO; ADAMTS5BEC-GOF + doxycycline | Slco1c1(BAC)-Cre; Krit1fl/fl; LSL-rtTA; tetO-Adamts5 | Increase in lesion formation | University of Pennsylvania | Mixed |
| Krit1ECKO; VcanRC/+ | VE-Cadherin-CreERT2; Krit1fl/fl; VcanRC/+ | Significant reduction in lesion formation | University of Pennsylvania | Mixed |